ClinicalTrials.Veeva

Menu

Patient and Caregiver Priorities in Neuro-oncology Care

Mayo Clinic logo

Mayo Clinic

Status

Enrolling

Conditions

Metastatic Malignant Neoplasm in the Central Nervous System
Malignant Central Nervous System Neoplasm

Treatments

Other: Non-Interventional Study

Study type

Observational

Funder types

Other

Identifiers

NCT06676306
NCI-2024-09052 (Registry Identifier)
24-000229 (Other Identifier)

Details and patient eligibility

About

This study is being done to identify patient and caregiver burdens regarding their experience with diagnosis and treatment of CNS tumors. These results will help doctors find areas where patients and caregivers may need more support.

Full description

PRIMARY OBJECTIVES:

I. Describe the patient experience and characterize the symptom burden related to primary or metastatic central nervous system tumors.

II. Describe the caregiver experience and caregiver needs related to patients with primary or metastatic central nervous system tumors. III. Establish which interventional treatment outcomes are important to patients and caregivers, within a wider understanding of their lived experience with CNS tumors and their treatment.

OUTLINE: This is an observational study.

Patients and their caregivers participate in interviews on study. Patients also have their medical records reviewed on study.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • * Age ≥ 18 years.

    • Diagnosis of primary or metastatic CNS tumor with a primary caregiver, should patient wish to involve one.
    • Willing and able to participate in a semi-structured interview lasting approximately 60 minutes. Dyad interviews conducted for participants who elect to involve a caregiver.
    • Willing and able to participate in a single follow-up interview. Dyad follow up interviews conducted for participants who elect to involve a caregiver.

Exclusion criteria

  • * Uncontrolled and/or intercurrent illness which limits participation in study interview.

    • Vulnerable populations: pregnant or nursing persons, prisoners, or persons lacking capacity for understanding.

    • Unable to read and speak English.

      • Note: English does not need to be primary language.

Trial design

80 participants in 1 patient group

Observational
Description:
Patients and their caregivers participate in interviews on study. Patients also have their medical records reviewed on study.
Treatment:
Other: Non-Interventional Study

Trial contacts and locations

1

Loading...

Central trial contact

Clinical Trials Referral Office

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems